This inventor holds 1 USPTO granted patent. Top assignee: Beth Israel Deaconess Medical Center, Inc.. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Innovations of Nicholas D Andersen
Introduction
Nicholas D Andersen is an accomplished inventor based in Boston, MA (US). He has made significant contributions to the field of medical science, particularly in the area of vascular health. His innovative work focuses on methods to inhibit smooth muscle cell migration and proliferation, which are critical in treating vascular proliferative diseases.
Latest Patents
Nicholas D Andersen holds 1 patent for his invention titled "Methods of inhibiting smooth muscle cell migration and proliferation." This patent outlines methods for inhibiting smooth muscle cell responses and provides strategies for treating or preventing vascular proliferative diseases caused by the migration and proliferation of these cells. The invention specifically details how to introduce agents into smooth muscle cells that inhibit the activity of members of the myristoylated alanine-rich C kinase substrate (MARCKS) family of proteins. Additionally, it includes methods for inhibiting the expression of genes encoding MARCKS family proteins in cells.
Career Highlights
Nicholas D Andersen is affiliated with Beth Israel Deaconess Medical Center, Inc., where he continues to advance his research and innovations. His work has the potential to significantly impact the treatment of vascular diseases, showcasing his dedication to improving patient outcomes through scientific discovery.
Collaborations
Some of his notable coworkers include Thomas S Monahan and Frank W LoGerfo, who have collaborated with him on various research projects. Their combined expertise contributes to the advancement of medical science and innovation.
Conclusion
Nicholas D Andersen's contributions to the field of vascular health through his innovative patent demonstrate his commitment to addressing critical medical challenges. His work exemplifies the importance of research and collaboration in the pursuit of effective treatments for vascular diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
